HomeAI · summaries
Storia in 7 fonti
Weight-loss drugs could help treat other health conditions. Here’s what could be next
The U.S. FDA on Friday approved the use of Eli Lilly's Mounjaro to reduce the chances of heart attack or stroke in high-risk patients with type 2 diabetes
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Mounjaro approved to reduce cardiovascular events in adults with diabetes
The FDA has approved tirzepatide for reduction of cardiovascular risk in adults with type 2 diabetes, Eli Lilly announced.Tirzepatide (Mounjaro), a dual GLP-1/glucose-dependent…
- ·
morningstar.com
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
